Within Europe , discussions surrounding AOD-9604 and its 5mg formulation are increasingly visible . While interest remains subdued compared to overseas markets, a small number of individuals are investigating its purported benefits. Available data is scarce , making definitive conclusions premature, and regulatory bodies maintain a restrained appro